Neuraxis Insider Trades
NYSE: NRXSHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 3 · $12.26K
- Sales
- 0 · $0
- Shares bought / sold
- 2.53K / 0
- Net activity
- Net buying $12,260
Neuraxis insider activity
Over the last 12 months, Neuraxis insiders reported 3 transactions on SEC Form 4: 3 open-market purchases and 0 sales. Insiders bought $12,260 and sold $0 worth of stock, for net insider buying of $12,260. The most recent filing shows Henrichs Timothy Robert (Chief Financial Officer) buying 1,937 shares at $4.84 on Oct 8, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NRXS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
NRXS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 8, 2026 | Carrico Brian AllenChief Executive Officer | Buy | 268 | $1.30K | Form 4 |
| Oct 8, 2026 | Carrico Thomas JoesephCRO, CCO, CPO | Buy | 328 | $1.59K | Form 4 |
| Oct 8, 2026 | Henrichs Timothy RobertChief Financial Officer | Buy | 1,937 | $9.38K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4